New Data Presented at the Annual European Congress of Rheumatology (EULAR 2016) Demonstrate Safety and Efficacy of Biogen’s Anti-TNF Biosimilars Portfolio
ZUG, Switzerland–(BUSINESS WIRE)– Data demonstrating long-term comparable efficacy, safety and immunogenicity of BENEPALI ®(etanercept) and FLIXABI ® (infliximab) were presented by Samsung Bioepis, the joint...